Oragenics Inc (OGEN) is not a strong buy at the moment for a beginner investor with a long-term strategy. The lack of positive financial performance, absence of significant trading trends, no recent news catalysts, and no proprietary trading signals suggest that this stock does not currently present a compelling investment opportunity.

Technical Analysis

The MACD is positive and expanding, indicating a bullish momentum. However, the RSI is in the neutral zone, and moving averages are converging, showing no clear trend. The pre-market price is up 2.42%, but the stock remains below key resistance levels (R1: 0.929).

Positive Catalysts

NULL identified. No recent news, trading trends, or significant external events to act as a positive catalyst.

Neutral/Negative Catalysts

Negative financial performance with declining EPS (-82.69% YoY) and no revenue growth. The net income remains negative, and there is no valuation data to support the stock's potential.

Financial Performance

In Q3 2025, revenue remained at 0 with no growth. Net income improved slightly but remains negative (-$3,066,589, up 24.51% YoY). EPS dropped significantly to -1.96 (-82.69% YoY). Gross margin is 0, indicating no profitability.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No data available for analyst ratings or price target changes.

Analyst Rating

Wall Street analysts forecast OGEN stock price to rise

Buy

Hold

Sell

Current: 0.840

Low

Averages

High